At a glance
ClinicalIndex Comparison RecordN/ACompleted· 128 enrolled
Drug / intervention
Dual-Energy Contrast-Enhanced (DECE) mammography +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pilot Study of Dual-energy (DE) Contrast-enhanced (CE) Digital Mammography to Detect Breast Cancer in Patients With Increased Breast Density (Breast Imaging-Reporting And Data System (BI-RADS) Category c or d)
In Brief
A clinical study evaluating Dual-Energy Contrast-Enhanced (DECE) mammography and digital mammography for Breast Cancer. Completed, enrolled 128 participants across 1 site.
Detailed Summary
This is a feasibility study to evaluate dual-energy (DE) contrast-enhanced (CE) digital mammography to detect breast cancer in patients with increased breast density (BI-RADS category c or d). Eligible patients will be invited to have full-field digital mammography and dual-energy (DE) contrast-enhanced (CE) digital mammography to compare accuracy of the imaging methods for the detection of breast cancer.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartNov 2015
First PostedDec 2016
Primary CompletionMay 2018
TodayJul 2026
First PostedDec 19, 2016
Enrollment StartNov 1, 2015
Primary CompletionMay 31, 2018
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 9.5 years ago
Interventions
Dual-Energy Contrast-Enhanced (DECE) mammographydevice
Contrast mammography
digital mammographydevice
routine digital mammography